Response to Comments: Off-Label Use of Intravenous Immune Globulin (IVIG)

This document records the response-to-comments process for the Off-Label Use of Intravenous Immune Globulin (IVIG) Local Coverage Determination, noting that public and provider comments were solicited. The official notice period for the final LCD begins on 2022-09-15 and the final determination becomes effective on 2022-11-01; no clinical coverage criteria or claim-level documentation requirements are specified in this notice.

"National Government Services solicited public and provider comments on the Off-Label Use of Intravenous Immune Globulin (IVIG) LCD; the official notice period for the final LCD begins 2022-09-15 an..."

Sign up to see full coverage criteria, indications, and limitations.